Plunkett Research Online: Idorsia

IDORSIA (IDRSF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing drugs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which .....



Idorsia
Ticker: IDRSF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 41 588440000
Fax:
Address: Hegenheimermattweg 91
Allschwil, 4123 Switzerland

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description
Jean-Paul Clozel CEO/Director
Mathieu Simon Chairman of the Board/Director
See More
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing drugs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which .....See More See More

Auditor: EY Basel
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: